What does DNLI company do? | Glauxie AI

Q: What does DNLI company do?

Denali Therapeutics Inc. (DNLI) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Ryan J. Watts. Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2... Employees: 30,000.

Q: Who is the CEO of DNLI?

Find out who leads DNLI — CEO name, executive team, and compensation details.

Q: What sector is DNLI in?

Find DNLI sector, industry, and sub-industry classification with sector peer comparison.

Q: What are DNLI competitors?

Compare DNLI to its top competitors with side-by-side financials, valuation, and performance.

What does DNLI company do?

🦉

Denali Therapeutics Inc. (DNLI)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEORyan J. Watts

Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in...

Key Executives

Name	Title
Alexander O. Schuth	Co-Founder, Chief Financial Officer, Chief Operating Officer & Secretary
Chris Walsh	General Counsel
Cindy Dunkle	Chief People Officer
Dana Andersen	Chief Technical and Manufacturing Officer
Joe Lewcock	Chief Scientific Officer
Katie Peng	Chief Commercial Officer

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

DNLI Profile Financials

Who is the CEO of DNLI? What sector is DNLI in? What are DNLI competitors?